Lung Cancer Screening Market: Growing at a CAGR of 8.1%

Lung Cancer Screening Market Size, Share By Cancer Type (Non-small Cell Lung Cancer (NSCLC), and Small Cell Lung Cancer); By Diagnosis Type (Low Dose Spiral CT Scan, and Chest X-ray), By End-user (Hospitals & Clinics, and Diagnostic Centres), and Regional Forecast 2028

Lung cancer is the leading cause of cancer death worldwide, and early detection is key to improving survival rates. The lung cancer screening market is growing at a CAGR of 8.1%, driven by the increasing prevalence of smoking, technological advancements in screening methods, and government initiatives to promote early detection. According To Research Done By Fortune Business Insights, The global lung cancer screening market size is projected to grow from USD 2.80 billion in 2021 to USD 4.85 billion in 2028

𝐆𝐞𝐭 𝐌𝐨𝐫𝐞 𝐈𝐧𝐬𝐢𝐠𝐡𝐭𝐬> https://www.fortunebusinessinsights.com/industry-reports/lung-cancer-screening-market-101174

The low-dose computed tomography (LDCT) scan is the most widely used screening method for lung cancer. LDCT scans can detect small tumours before they cause symptoms when they are more likely to be successfully treated.

The lung cancer screening market is segmented by cancer type, technology, age group, and end user. The non-small cell lung cancer (NSCLC) segment is the largest segment, and the LDCT scan is the most commonly used technology. The market is also growing in the elderly population, as the risk of lung cancer increases with age.

The lung cancer screening market is a promising market with significant growth potential. The increasing prevalence of smoking, technological advancements, and government initiatives are driving the growth of the market.

Lungenkrebs-Screening-Marktgröße > https://www.fortunebusinessinsights.com/de/industrie-berichte/lungenkrebs-screening-markt-101174

肺がん検診市場 > https://www.fortunebusinessinsights.com/jp/業界-レポート/肺がん検診市場-101174